{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T21:26:42Z","timestamp":1774474002320,"version":"3.50.1"},"reference-count":35,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T00:00:00Z","timestamp":1633737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001656","name":"Helmholtz-Gemeinschaft","doi-asserted-by":"publisher","award":["iMed"],"award-info":[{"award-number":["iMed"]}],"id":[{"id":"10.13039\/501100001656","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>External validation in different cohorts is a key step in the translational development of new biomarkers. We previously described three host mRNA whose expression in peripheral blood is significantly higher (NPC2) or lower (DOCK9 and EPHA4) in individuals with TB compared to latent TB infection (LTBI) and controls. We have now conducted an independent validation of these genes by re-analyzing publicly available transcriptomic datasets from Brazil, China, Haiti, India, South Africa, and the United Kingdom. Comparisons between TB and control\/LTBI showed significant differential expression of all three genes (NPC2high\u00a0p &lt; 0.01, DOCK9low\u00a0p &lt; 0.01, and EPHA4low\u00a0p &lt; 0.05). NPC2high had the highest mean area under the ROC curve (AUROC) for the differentiation of TB vs. controls (0.95) and LTBI (0.94). In addition, NPC2 accurately distinguished TB from the clinically similar conditions pneumonia (AUROC, 0.88), non-active sarcoidosis (0.87), and lung cancer (0.86), but not from active sarcoidosis (0.66). Interestingly, individuals progressing from LTBI to TB showed a constant increase in NPC2 expression with time when compared to non-progressors (p &lt; 0.05), with a significant change closer to manifestation of active disease (\u22643 months, p = 0.003). Moreover, NPC2 expression normalized with completion of anti-TB treatment. Taken together, these results validate NPC2 mRNA as a diagnostic host biomarker for active TB independent of host genetic background. Moreover, they reveal its potential to predict progression from latent to active infection and to indicate a response to anti-TB treatment.<\/jats:p>","DOI":"10.3390\/cells10102704","type":"journal-article","created":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T21:19:32Z","timestamp":1633900772000},"page":"2704","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Transcriptomic Biomarkers for Tuberculosis: Validation of NPC2 as a Single mRNA Biomarker to Diagnose TB, Predict Disease Progression, and Monitor Treatment Response"],"prefix":"10.3390","volume":"10","author":[{"given":"Leonardo S.","family":"de Araujo","sequence":"first","affiliation":[{"name":"Cellular Microbiology Laboratory, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro 20045-360, Brazil"},{"name":"Research Group Biomarkers for Infectious Diseases, TWINCORE Centre for Experimental and Clinical Infection Research, 30519 Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8663-3364","authenticated-orcid":false,"given":"Marcelo","family":"Ribeiro-Alves","sequence":"additional","affiliation":[{"name":"National Institute of Infectology Evandro Chagas, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro 21040-360, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1436-3366","authenticated-orcid":false,"given":"Matthew F.","family":"Wipperman","sequence":"additional","affiliation":[{"name":"Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA"},{"name":"Clinical and Translational Science Center, Weill Cornell Medicine, New York, NY 10021, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles Kyriakos","family":"Vorkas","sequence":"additional","affiliation":[{"name":"Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA"},{"name":"Division of Infectious Diseases, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3434-2311","authenticated-orcid":false,"given":"Frank","family":"Pessler","sequence":"additional","affiliation":[{"name":"Research Group Biomarkers for Infectious Diseases, TWINCORE Centre for Experimental and Clinical Infection Research, 30519 Hannover, Germany"},{"name":"Centre for Individualised Infection Medicine, 30625 Hannover, Germany"},{"name":"Helmholtz Center for Infection Research, 38124 Braunschweig, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Helena F\u00e9res","family":"Saad","sequence":"additional","affiliation":[{"name":"Cellular Microbiology Laboratory, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro 20045-360, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,9]]},"reference":[{"key":"ref_1","unstructured":"WHO (2020). Global Tuberculosis Report, WHO."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0140-6736(00)02742-2","article-title":"Specific immune-based diagnosis of tuberculosis","volume":"356","author":"Andersen","year":"2000","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"654","DOI":"10.5694\/mja13.11007","article-title":"Immigration screening for latent tuberculosis infection","volume":"199","author":"Denholm","year":"2013","journal-title":"Med. J. Aust."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"521","DOI":"10.12659\/MSM.889943","article-title":"Performance of QuantiFERON-TB Gold In-Tube test and Tuberculin Skin Test for diagnosis of latent tuberculosis infection in BCG vaccinated health care workers","volume":"20","author":"Gocmen","year":"2014","journal-title":"Med. Sci. Monit."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Behr, M.A., Kaufmann, E., Duffin, J., Edelstein, P.H., and Ramakrishnan, L. (2021). Latent Tuberculosis: Two Centuries of Confusion. Am. J. Respir. Crit. Care Med.","DOI":"10.1164\/rccm.202011-4239PP"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S2213-2600(19)30469-2","article-title":"Blood transcriptional biomarkers for active pulmonary tuberculosis in a high-burden setting: A prospective, observational, diagnostic accuracy study","volume":"8","author":"Turner","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.tube.2017.08.004","article-title":"Host blood RNA signatures predict the outcome of tuberculosis treatment","volume":"107","author":"Thompson","year":"2017","journal-title":"Tuberculosis"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S2213-2600(19)30282-6","article-title":"Concise whole blood transcriptional signatures for incipient tuberculosis: A systematic review and patient-level pooled meta-analysis","volume":"8","author":"Gupta","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_9","unstructured":"World Health Organization (2014). High-Priority Target Product Profiles for New Tuberculosis Diagnostics Report of a Consensus Meeting, World Health Organization."},{"key":"ref_10","first-page":"1586","article-title":"Transcriptomic Biomarkers for Tuberculosis: Evaluation of DOCK9, EPHA4, and NPC2 mRNA Expression in Peripheral Blood","volume":"7","author":"Vaas","year":"2016","journal-title":"Front. Microbiol."},{"key":"ref_11","first-page":"6","article-title":"Reprogramming of small non-coding RNA populations in peripheral blood reveals host biomarkers for latent and active Mycobacterium tuberculosis Infection","volume":"10","author":"Leung","year":"2019","journal-title":"mBio"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1126\/science.1174468","article-title":"Activation of Rho GTPases by DOCK Exchange Factors Is Mediated by a Nucleotide Sensor","volume":"325","author":"Yang","year":"2009","journal-title":"Science"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1091\/mbc.e06-04-0294","article-title":"EphA4 signaling regulates blastomere adhesion in the Xenopus embryo by recruiting Pak1 to suppress Cdc42 function","volume":"18","author":"Bisson","year":"2007","journal-title":"Mol. Biol. Cell"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.autrev.2008.07.044","article-title":"Rho GTPase-mediated pathways in mature CD4+ T cells","volume":"8","author":"Pernis","year":"2009","journal-title":"Autoimmun. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"15223","DOI":"10.1073\/pnas.0808256105","article-title":"NPC1\/NPC2 function as a tag team duo to mobilize cholesterol: Fig","volume":"105","author":"Subramanian","year":"2008","journal-title":"1. Proc. Natl. Acad. Sci. USA"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/abbs\/gmr119","article-title":"OxLDL up-regulates Niemann-Pick type C1 expression through ERK1\/2\/COX-2\/PPAR -signaling pathway in macrophages","volume":"44","author":"Yu","year":"2012","journal-title":"Acta Biochim. et Biophys. Sin."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Tseng, W.-C., Loeb, H.E., Pei, W., Morris, C.H.T., Xu, L., Cluzeau, C.V., Wassif, C.A., Feldman, B., Burgess, S.M., and Pavan, W.J. (2018). Modeling Niemann-Pick disease type C1 in zebrafish: A robust platform for in vivo screening of candidate therapeutic compounds. Dis. Model. Mech., 11.","DOI":"10.1242\/dmm.034165"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.4049\/jimmunol.1301686","article-title":"All-TransRetinoic Acid\u2013Triggered Antimicrobial Activity against Mycobacterium tuberculosis Is Dependent on NPC2","volume":"192","author":"Wheelwright","year":"2014","journal-title":"J. Immunol."},{"key":"ref_19","unstructured":"World Health Organization (2017). Development of a Target Product Profile (TPP) and a Framework for Evaluation for a Test for Predicting Progression from Tuberculosis Infection to Active Disease, World Health Organization."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Walsh, K.F., McAulay, K., Lee, M.H., Vilbrun, S.C., Mathurin, L., Francois, D.J., Zimmerman, M., Kaya, F., Zhang, N., and Saito, K. (2020). Early Bactericidal Activity Trial of Nitazoxanide for Pulmonary Tuberculosis. Antimicrob. Agents Chemother., 64.","DOI":"10.1128\/AAC.01956-19"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-21475-y","article-title":"Gastrointestinal microbiota composition predicts peripheral inflammatory state during treatment of human tuberculosis","volume":"12","author":"Wipperman","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"D562","DOI":"10.1093\/nar\/gki022","article-title":"NCBI GEO: Mining millions of expression profiles--database and tools","volume":"33","author":"Barrett","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Bloom, C.I., Berry, M.P., Rozakeas, F., Redford, P.S., Wang, Y., Xu, Z., Wilkinson, K.A., Wilkinson, R.J., Kendrick, Y., and Devouassoux, G. (2013). Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sar-coidosis, pneumonias and lung cancers. PLoS ONE, 8.","DOI":"10.1371\/annotation\/7d9ec449-aee0-48fe-8111-0c110850c0c1"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1164\/rccm.201711-2340OC","article-title":"Four-Gene Pan-African Blood Signature Predicts Progression to Tuberculosis","volume":"197","author":"Suliman","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Cai, Y., Yang, Q., Tang, Y., Zhang, M., Liu, H., Zhang, G., Deng, Q., Huang, J., Gao, Z., and Zhou, B. (2014). Increased Complement C1q Level Marks Active Disease in Human Tuberculosis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0092340"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.tube.2018.01.002","article-title":"Existing blood transcriptional classifiers accurately discriminate active tuberculosis from latent infection in individuals from south India","volume":"109","author":"Leong","year":"2018","journal-title":"Tuberculosis"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"D991","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI GEO: Archive for functional genomics data sets\u2013update","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"ref_28","first-page":"1","article-title":"GREIN: An Interactive Web Platform for Re-analyzing GEO RNA-seq Data","volume":"9","author":"Najafabadi","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/nbt.3001","article-title":"The concordance between RNA-seq and microarray data depends on chemical treatment and transcript abundance","volume":"32","author":"Wang","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0140-6736(98)12310-3","article-title":"Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis","volume":"354","author":"Ishige","year":"1999","journal-title":"Lancet"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1165\/rcmb.2010-0433TR","article-title":"Evidence for Mycobacteria in Sarcoidosis","volume":"45","author":"Brownell","year":"2011","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_32","first-page":"541","article-title":"Frequent isolation of propionibacterium acnes from sarcoidosis lymph nodes","volume":"256","author":"Abe","year":"1984","journal-title":"Zent. Bakteriol. Mikrobiol. Hygiene. 1. Abt. Originale. A Med. Mikrobiol. Infekt. Parasitol."},{"key":"ref_33","first-page":"251","article-title":"Bacteriological investigation on biopsy specimens from patients with sarcoidosis","volume":"48","author":"Homma","year":"1978","journal-title":"Jpn. J. Exp. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ymeth.2012.08.012","article-title":"Transcriptional biomarkers\u2014High throughput screening, quantitative verification, and bioinformatical validation methods","volume":"59","author":"Riedmaier","year":"2013","journal-title":"Methods"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Theron, G., Venter, R., Smith, L., Esmail, A., Randall, P., Sood, V., Oelfese, S., Calligaro, G., Warren, R., and Dheda, K. (2018). False-Positive Xpert MTB\/RIF Results in Retested Patients with Previous Tuberculosis: Frequency, Profile, and Prospective Clinical Outcomes. J. Clin. Microbiol., 56.","DOI":"10.1128\/JCM.01696-17"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/10\/10\/2704\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:10:54Z","timestamp":1760166654000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/10\/10\/2704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,9]]},"references-count":35,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["cells10102704"],"URL":"https:\/\/doi.org\/10.3390\/cells10102704","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,9]]}}}